Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
MDGL: Madrigal Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
MDGL
The Story
MDGL
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
-27.7%
ROIC
-37.0%
Financially safe
Stretched
Debt / equity
0.66×
Interest coverage
-11.7×
Current ratio
3.20×
Madrigal Pharmaceuticals, Inc.
MDGL
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Madrigal Pharmaceuticals, Inc.
MDGL
NASDAQ
·
USD
·
Closed
$467.32
−5.23%
$467.32
−$25.79 (5.23%)
52W Range
53th
pctl
Volume
2.24×
avg
Mkt Cap
10.77B
USD
P/E
-42.4
TTM
Div Yield
–
ann
52W Range
53th
pctl
Volume
2.24×
avg
Market Cap
10.77B
USD
P/E Ratio
-42.4
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings